Hispanics are the largest minority group in the United States. They are disproportionately affected by diabetes and are twice as likely to develop diabetes then are non-Hispanic white adults. Mexican Americans are the largest subpopulation of Hispanics in the United States and one out of ten has diabetes. The purpose of this qualitative descriptive study was to explore the experiences of adults of Mexican origin who were newly informed of having elevated glucose levels in the diabetes range. This qualitative inquiry was conducted by means of in-depth semi-structured interviews with eight individuals of Mexican origin who had been recently informed of having hyperglycemic values exceeding the threshold of diabetes. A modified version of Kleinman's explanatory model of illness was used to elicit the EM of high blood sugar of the study participants. Qualitative content analysis was utilized to analyze the data. Domains, categories and subcategories were elicited through the immersion and crystallization of thematic units attained through the in-depth, semi-structured interviews. Three overarching domains emerged describing the experience and perception the participants had of being newly informed of having high blood sugar: 1) EM of High Blood Sugar 2) Response to Being Informed of High Blood Sugar 3) Facilitators and Barriers to Seeking Care. The participants describe a Temporal Order of how they responded to being informed of having high blood sugar. Facilitators, barriers and gaps to seeking care was also discussed. This study provides valuable insight that can influence the development of culturally relevant interventions that may promote behavior changes to reduce blood glucose levels and promote healthy outcomes for this population.

In 2013 Burma, the country of origin for many refugees of whom have resettled in the U.S. was in the top three countries for notification of suspected Latent Tuberculosis Infection (LTBI). Approximately 5%-10% of individuals diagnosed with LTBI are at risk of developing active tuberculosis (TB) disease; the highest risk occurs within two years following the diagnosis. Burmese refugees face a high potential of developing LTBI during resettlement in the U.S. and are at high risk for subsequent TB. Currently, we have limited knowledge of the Burmese Chin refugees' explanatory model (EM) of LTBI. Understanding the EM of these refugees is important because one's EM facilitates the recognition and response to illness, including early diagnosis and treatment. In the context of LTBI, this relates to the potential prevention of active TB disease. The purpose of this ethnographic study was to discover the Burmese Chin refugees' EM of LTBI and to describe the barriers experienced in receiving LTBI treatment. Kleinman's EM provided a conceptual framework to guide this study. A Burmese refugee gatekeeper assisted with community immersion and participant recruitment. Purposive and snowball sampling were used to recruit participants. Data were collected through participant observation and semi-structured interviews. Three data analysis strategies for ethnography that were used included domain, taxonomic, and componential analyses. Domain analysis began after open, inductive coding of the data. Data saturation was reached and the research questions were answered with eight participants. Data from 15 key informant interviews were abstracted into three domains: EM of LTBI, Fear and Stigmatization, and Barriers to Receiving LTBI Treatment. The over-arching theme, LTBI: My Shadowbox was derived from these three domains, 11 categories, and 25 subcategories through iterative and inductive data analysis. The analysis revealed the participants' language, behavior patterns, beliefs, values and health seeking experiences of LTBI in the U.S. The findings from this study will help to inform culturally tailored interventions to reduce LTBI and TB health disparities among Burmese Chin refugees and potentially other Burmese refugee subgroups in the U.S. Knowledge of the Burmese Chin refugees' EM of LTBI can inform health policy for reducing LTBI treatment barriers.